About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in California | 51,582 Studies Near You

Clinical TrialsCalifornia

Clinical Trials in California

Discover 51,582 clinical trials near California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7721-7740 of 51,582 trials

CompletedPexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)During a heart bypass procedure, a substance called "complement" is activated by the body.NCT00088179·Birmingham, Alabama and 187 others

Find Trials by Condition in California

Breast Cancerin California Lung Cancerin California Prostate Cancerin California Colorectal Cancerin California Melanomain California Leukemiain California Lymphomain California Pancreatic Cancerin California Ovarian Cancerin California Brain Cancerin California

Data from ClinicalTrials.govTerms

TerminatedStudy of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)Determining the efficacy, based upon overall survival, of ruxolitinib added to capecitabine for the treatment of advanced or metastatic pancreatic cancer.NCT02117479·Avondale, Arizona and 229 others

RecruitingRadiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0Multi-center, prospective, non-randomized study to evaluate outcomes of surgically treated patients with adult cervical spinal deformity.NCT04194996·La Jolla, California and 15 others

RecruitingA Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBCThis study is being conducted to evaluate the safety and tolerability of UGN-501 administered intravesically in adult participants with recurrent non-muscle invasive bladder…NCT07725796·Queen Creek, Arizona and 14 others

CompletedDeveloping e-Health Systems to Improve Growth and Nutrition in CFBeing at or above the 50th percentile body mass index (BMI) for age and gender in children with cystic fibrosis (CF) is associated with better lung functioning as measured by…NCT03635762·Stanford, California and 6 others

WithdrawnAndrogen Reduction in Congenital Adrenal HyperplasiaChildren with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency tend to have elevated circulating levels of androgens, which can accelerate skeletal maturation…NCT03548246·Los Angeles, California and 3 others

CompletedA Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and PharmacodynamicsThe purpose of this study is to see if GSK1292263 is safe and well-tolerated when administered to type 2 diabetics, and to get preliminary information about whether it may be…NCT01119846·Phoenix, Arizona and 6 others

RecruitingOutcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)The goal of this observational study is to learn about the effectiveness of tirbanibulin among adult subjects with actinic keratosis (AK) lesions in the face.NCT07657988·Manhattan Beach, California and 1 other

CompletedABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with…NCT05507203·Dothan, Alabama and 263 others

CompletedSafety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesThis study will investigate the efficacy and safety of two doses (high and low) of empagliflozin in combination with metformin (500 mg and 1000 mg) administered twice daily in…NCT01719003·Birmingham, Alabama and 189 others

CompletedInitial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)The Patient-Reported Outcomes Measurement Information System (PROMIS) is an NIH Roadmap initiative to develop a computerized system measuring patient-reported outcomes in…NCT00786227·Palo Alto, California

CompletedStudy of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin AlfaThis is a Phase 2 open-label efficacy, safety, and pharmacokinetic/pharmacodynamic (PK/PD) study to evaluate oral Vadadustat for the treatment of anemia in hemodialysis…NCT03799627·Fresno, California and 40 others

CompletedM7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)The study to evaluate M7824 monotherapy in participants with advanced or metastatic biliary tract cancer (BTC) who failed or were intolerant to first-line (1L) chemotherapy.NCT03833661·Scottsdale, Arizona and 32 others

WithdrawnTargeted PET/CT and PET/MRI Imaging of Vascular InflammationStroke and abdominal aortic aneurysms (AAAs) are common and highly lethal vascular diseases.NCT02995642·Stanford, California

TerminatedSafety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung CancerThe goal of this clinical trial is to compare the safety and efficacy (how well the drug works) of acasunlimab (also known as GEN1046) when it is used alone (monotherapy) versus…NCT05117242·Santa Rosa, California and 39 others

CompletedStudy to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell TransplantationThis is a Phase Ib, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of Efmarodocokin Alfa and to make a preliminary…NCT04539470·Duarte, California and 7 others

TerminatedPhase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous UrticariaPhase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects with Chronic Spontaneous UrticariaNCT06077773·Birmingham, Alabama and 47 others

CompletedThe Impact of Family Financial Support on Health Related Quality of LifeThe investigators have partnered with financial coaching organizations to establish what the investigators have termed a "Medical-Financial Partnership (MFP)" that offers…NCT02722005·Los Angeles, California

CompletedA Phase I/II Study of HE3235 in Patients With Prostate CancerThis is a phase I/II, open-label, dose escalation study of HE3235 administered orally to patients with advanced prostate cancer who have failed hormone therapy and at least one…NCT00716794·Scottsdale, Arizona and 7 others

CompletedSafety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation RecipientsThe purpose of this study is to evaluate the safety of alemtuzumab after kidney transplantation as part of a multitherapy regimen to prevent kidney graft loss and death and to…NCT00240994·San Francisco, California and 3 others

PreviousPage 387 of 2580Next

Diabetes

in California

Heart Diseasein California